ongoing trials trial from www.clinicaltrials.gov A Study to Evaluate Safety and Efficacy of Subcutaneous Administration of Anakinra in Patients With CF - Phase 2 - Not yet recruiting Year: 2019 Date: October 1, 2019 Author: Heidelberg University Source https://ClinicalTrials.gov/show/NCT03925194 Study design (if review, criteria of inclusion for studies) Interventional - Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment Participants Cystic Fibrosis - 12 Years and older (Child, Adult, Older Adult) Interventions Drug: Anakinra Outcome measures Absolute pre-post change of the lung clearance index (LCI)